Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.95 is 58% below its 5-year average of 4.68, near the low end of its 5-year range (1.95–13.50).
As of the fiscal period ended Tuesday, June 30, 2026. 21.89% below its 12-month average of 2.50.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.95.
QUICK RATIO (ACID-TEST)
1.95
QUICK RATIO (ACID-TEST) AVG TTM
2.50
QUICK RATIO (ACID-TEST) AVG 3Y
3.08
QUICK RATIO (ACID-TEST) AVG 5Y
4.68
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-21.89%
CURRENT VS 3Y AVG
-36.74%
CURRENT VS 5Y AVG
-58.32%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
-41.88%
vs the sector median at left
Treace Medical Concepts, Inc.
Market Cap
$259.49M
Quick Ratio (Acid-Test)
1.95
TTM Avg
2.50
3Y Avg
3.08
5Y Avg
4.68
Market Cap
$259.56M
Quick Ratio (Acid-Test)
7.68
TTM Avg
7.37
3Y Avg
6.66
5Y Avg
5.96
Market Cap
$259.14M
Quick Ratio (Acid-Test)
16.00
TTM Avg
13.11
3Y Avg
8.33
5Y Avg
7.81
Market Cap
$259.12M
Quick Ratio (Acid-Test)
13.89
TTM Avg
8.37
3Y Avg
7.38
5Y Avg
15.00
Market Cap
$258.63M
Quick Ratio (Acid-Test)
24.26
TTM Avg
16.09
3Y Avg
10.56
5Y Avg
7.83
Market Cap
$261.27M
Quick Ratio (Acid-Test)
11.02
TTM Avg
6.66
3Y Avg
6.10
5Y Avg
6.28
Market Cap
$261.43M
Quick Ratio (Acid-Test)
15.82
TTM Avg
24.04
3Y Avg
14.70
5Y Avg
12.06
Market Cap
$256.47M
Quick Ratio (Acid-Test)
0.93
TTM Avg
1.36
3Y Avg
5.78
5Y Avg
8.29
Market Cap
$262.92M
Quick Ratio (Acid-Test)
4.97
TTM Avg
2.08
3Y Avg
1.48
5Y Avg
1.89
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Treace Medical Concepts, Inc. (TMCI) | $259.49M | 1.95 | 2.50 | 3.08 | 4.68 |
| OraSure Technologies, Inc. (OSUR)vs › | $259.56M | 7.68 | 7.37 | 6.66 | 5.96 |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.14M | 16.00 | 13.11 | 8.33 | 7.81 |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $259.12M | 13.89 | 8.37 | 7.38 | 15.00 |
| Palisade Bio, Inc. (PALI)vs › | $258.63M | 24.26 | 16.09 | 10.56 | 7.83 |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $261.27M | 11.02 | 6.66 | 6.10 | 6.28 |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | 15.82 | 24.04 | 14.70 | 12.06 |
| AC Immune S.A. (ACIU)vs › | $256.47M | 0.93 | 1.36 | 5.78 | 8.29 |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | 4.97 | 2.08 | 1.48 | 1.89 |
| Anika Therapeutics, Inc. (ANIK)vs › | $255.88M | 3.19 | 3.85 | 4.21 | 4.14 |
Quick Ratio
1.95
Excludes inventory
Current Ratio
2.90
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.95 |
| 2026-03-31 | 2.53 |
| 2025-12-31 | 3.13 |
| 2025-09-30 | 2.36 |
| 2025-06-30 | 2.51 |
| 2025-03-31 | 3.36 |
| 2024-12-31 | 3.50 |
| 2024-09-30 | 2.98 |
| 2024-06-30 | 2.93 |
| 2024-03-31 | 3.22 |
| 2023-12-31 | 3.76 |
| 2023-09-30 | 4.76 |
| 2023-06-30 | 5.73 |
| 2023-03-31 | 8.61 |
| 2022-12-31 | 3.77 |
| 2022-09-30 | 4.92 |
| 2022-06-30 | 7.33 |
| 2022-03-31 | 7.56 |
| 2021-12-31 | 7.00 |
| 2021-09-30 | 11.66 |
| 2021-06-30 | 13.50 |
| 2021-03-31 | 3.39 |
| 2020-12-31 | 2.86 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
